Global Human Recombinant Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Human Recombinant Insulin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Human Recombinant Insulin Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Rapid-Acting Human Insulin
1.2.3 Regular (Short Acting) Insulin
1.2.4 NPH (Intermediate Acting) Insulin
1.2.5 Long-Acting Human Insulin
1.2.6 Premixed Human Insulins Insulin
1.3 Market Segment by Application
1.3.1 Global Human Recombinant Insulin Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Human Recombinant Insulin Market Size (2017-2028)
2.1.1 Global Human Recombinant Insulin Revenue (2017-2028)
2.1.2 Global Human Recombinant Insulin Sales (2017-2028)
2.2 Global Human Recombinant Insulin Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Human Recombinant Insulin Sales by Regions (2017-2022)
2.2.2 Global Human Recombinant Insulin Revenue by Regions (2017-2022)
2.3 Global Human Recombinant Insulin Market Size Forecast by Region
2.3.1 Global Human Recombinant Insulin Sales Forecast by Region (2023-2028)
2.3.2 Global Human Recombinant Insulin Revenue Forecast by Region (2023-2028)
2.4 Global Top Human Recombinant Insulin Regions (Countries) Ranking by Market Size
2.5 Human Recombinant Insulin Market Dynamics
2.5.1 Human Recombinant Insulin Market Trends
2.5.2 Human Recombinant Insulin Market Drivers
2.5.3 Human Recombinant Insulin Market Challenges
2.5.4 Human Recombinant Insulin Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Human Recombinant Insulin Manufacturers by Sales (2017-2022)
3.1.1 Global Human Recombinant Insulin Sales by Manufacturers (2017-2022)
3.1.2 Global Human Recombinant Insulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Human Recombinant Insulin Sales in 2021
3.2 Global Top Manufacturers Human Recombinant Insulin by Revenue
3.2.1 Global Human Recombinant Insulin Revenue by Manufacturers (2017-2022)
3.2.2 Top Human Recombinant Insulin Manufacturers Covered: Ranking by Revenue
3.2.3 Global Human Recombinant Insulin Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Human Recombinant Insulin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Recombinant Insulin as of 2021)
3.4 Global Human Recombinant Insulin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Human Recombinant Insulin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Human Recombinant Insulin Market
3.7 Key Manufacturers Human Recombinant Insulin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Human Recombinant Insulin Market Size by Type
4.1 Global Human Recombinant Insulin Historic Market Review by Type (2017-2022)
4.1.1 Global Human Recombinant Insulin Sales Market Share by Type (2017-2022)
4.1.2 Global Human Recombinant Insulin Revenue Market Share by Type (2017-2022)
4.1.3 Human Recombinant Insulin Price by Type (2017-2022)
4.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Human Recombinant Insulin Sales Forecast by Type (2023-2028)
4.2.2 Global Human Recombinant Insulin Revenue Forecast by Type (2023-2028)
4.2.3 Human Recombinant Insulin Price Forecast by Type (2023-2028)
5 Global Human Recombinant Insulin Market Size by Application
5.1 Global Human Recombinant Insulin Historic Market Review by Application (2017-2022)
5.1.1 Global Human Recombinant Insulin Sales Market Share by Application (2017-2022)
5.1.2 Global Human Recombinant Insulin Revenue Market Share by Application (2017-2022)
5.1.3 Human Recombinant Insulin Price by Application (2017-2022)
5.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Human Recombinant Insulin Sales Forecast by Application (2023-2028)
5.2.2 Global Human Recombinant Insulin Revenue Forecast by Application (2023-2028)
5.2.3 Human Recombinant Insulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Recombinant Insulin Sales Breakdown by Company
6.1.1 North America Human Recombinant Insulin Sales by Company (2017-2022)
6.1.2 North America Human Recombinant Insulin Revenue by Company (2017-2022)
6.2 North America Human Recombinant Insulin Market Size by Type
6.2.1 North America Human Recombinant Insulin Sales by Type (2017-2028)
6.2.2 North America Human Recombinant Insulin Revenue by Type (2017-2028)
6.3 North America Human Recombinant Insulin Market Size by Application
6.3.1 North America Human Recombinant Insulin Sales by Application (2017-2028)
6.3.2 North America Human Recombinant Insulin Revenue by Application (2017-2028)
6.4 North America Human Recombinant Insulin Market Size by Country
6.4.1 North America Human Recombinant Insulin Sales by Country (2017-2028)
6.4.2 North America Human Recombinant Insulin Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Human Recombinant Insulin Sales Breakdown by Company
7.1.1 Europe Human Recombinant Insulin Sales by Company (2017-2022)
7.1.2 Europe Human Recombinant Insulin Revenue by Company (2017-2022)
7.2 Europe Human Recombinant Insulin Market Size by Type
7.2.1 Europe Human Recombinant Insulin Sales by Type (2017-2028)
7.2.2 Europe Human Recombinant Insulin Revenue by Type (2017-2028)
7.3 Europe Human Recombinant Insulin Market Size by Application
7.3.1 Europe Human Recombinant Insulin Sales by Application (2017-2028)
7.3.2 Europe Human Recombinant Insulin Revenue by Application (2017-2028)
7.4 Europe Human Recombinant Insulin Market Size by Country
7.4.1 Europe Human Recombinant Insulin Sales by Country (2017-2028)
7.4.2 Europe Human Recombinant Insulin Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Recombinant Insulin Sales Breakdown by Company
8.1.1 Asia Pacific Human Recombinant Insulin Sales by Company (2017-2022)
8.1.2 Asia Pacific Human Recombinant Insulin Revenue by Company (2017-2022)
8.2 Asia Pacific Human Recombinant Insulin Market Size by Type
8.2.1 Asia Pacific Human Recombinant Insulin Sales by Type (2017-2028)
8.2.2 Asia Pacific Human Recombinant Insulin Revenue by Type (2017-2028)
8.3 Asia Pacific Human Recombinant Insulin Market Size by Application
8.3.1 Asia Pacific Human Recombinant Insulin Sales by Application (2017-2028)
8.3.2 Asia Pacific Human Recombinant Insulin Revenue by Application (2017-2028)
8.4 Asia Pacific Human Recombinant Insulin Market Size by Region
8.4.1 Asia Pacific Human Recombinant Insulin Sales by Region
8.4.2 Asia Pacific Human Recombinant Insulin Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Human Recombinant Insulin Sales Breakdown by Company
9.1.1 Latin America Human Recombinant Insulin Sales by Company (2017-2022)
9.1.2 Latin America Human Recombinant Insulin Revenue by Company (2017-2022)
9.2 Latin America Human Recombinant Insulin Market Size by Type
9.2.1 Latin America Human Recombinant Insulin Sales by Type (2017-2028)
9.2.2 Latin America Human Recombinant Insulin Revenue by Type (2017-2028)
9.3 Latin America Human Recombinant Insulin Market Size by Application
9.3.1 Latin America Human Recombinant Insulin Sales by Application (2017-2028)
9.3.2 Latin America Human Recombinant Insulin Revenue by Application (2017-2028)
9.4 Latin America Human Recombinant Insulin Market Size by Country
9.4.1 Latin America Human Recombinant Insulin Sales by Country (2017-2028)
9.4.2 Latin America Human Recombinant Insulin Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Recombinant Insulin Sales Breakdown by Company
10.1.1 Middle East and Africa Human Recombinant Insulin Sales by Company (2017-2022)
10.1.2 Middle East and Africa Human Recombinant Insulin Revenue by Company (2017-2022)
10.2 Middle East and Africa Human Recombinant Insulin Market Size by Type
10.2.1 Middle East and Africa Human Recombinant Insulin Sales by Type (2017-2028)
10.2.2 Middle East and Africa Human Recombinant Insulin Revenue by Type (2017-2028)
10.3 Middle East and Africa Human Recombinant Insulin Market Size by Application
10.3.1 Middle East and Africa Human Recombinant Insulin Sales by Application (2017-2028)
10.3.2 Middle East and Africa Human Recombinant Insulin Revenue by Application (2017-2028)
10.4 Middle East and Africa Human Recombinant Insulin Market Size by Country
10.4.1 Middle East and Africa Human Recombinant Insulin Sales by Country (2017-2028)
10.4.2 Middle East and Africa Human Recombinant Insulin Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Human Recombinant Insulin Products and Services
11.1.5 Novo Nordisk Human Recombinant Insulin SWOT Analysis
11.1.6 Novo Nordisk Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Corporation Information
11.2.2 Eli Lilly and Company Overview
11.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Eli Lilly and Company Human Recombinant Insulin Products and Services
11.2.5 Eli Lilly and Company Human Recombinant Insulin SWOT Analysis
11.2.6 Eli Lilly and Company Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sanofi Human Recombinant Insulin Products and Services
11.3.5 Sanofi Human Recombinant Insulin SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Julphar Gulf Pharmaceutical Industries
11.4.1 Julphar Gulf Pharmaceutical Industries Corporation Information
11.4.2 Julphar Gulf Pharmaceutical Industries Overview
11.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Products and Services
11.4.5 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin SWOT Analysis
11.4.6 Julphar Gulf Pharmaceutical Industries Recent Developments
11.5 Bioton
11.5.1 Bioton Corporation Information
11.5.2 Bioton Overview
11.5.3 Bioton Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Bioton Human Recombinant Insulin Products and Services
11.5.5 Bioton Human Recombinant Insulin SWOT Analysis
11.5.6 Bioton Recent Developments
11.6 Gan & Lee Pharmaceuticals
11.6.1 Gan & Lee Pharmaceuticals Corporation Information
11.6.2 Gan & Lee Pharmaceuticals Overview
11.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Products and Services
11.6.5 Gan & Lee Pharmaceuticals Human Recombinant Insulin SWOT Analysis
11.6.6 Gan & Lee Pharmaceuticals Recent Developments
11.7 Zhuhai United Laboratories
11.7.1 Zhuhai United Laboratories Corporation Information
11.7.2 Zhuhai United Laboratories Overview
11.7.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Zhuhai United Laboratories Human Recombinant Insulin Products and Services
11.7.5 Zhuhai United Laboratories Human Recombinant Insulin SWOT Analysis
11.7.6 Zhuhai United Laboratories Recent Developments
11.8 Biocon
11.8.1 Biocon Corporation Information
11.8.2 Biocon Overview
11.8.3 Biocon Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Biocon Human Recombinant Insulin Products and Services
11.8.5 Biocon Human Recombinant Insulin SWOT Analysis
11.8.6 Biocon Recent Developments
11.9 Wanbang Biopharmaceuticals
11.9.1 Wanbang Biopharmaceuticals Corporation Information
11.9.2 Wanbang Biopharmaceuticals Overview
11.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Products and Services
11.9.5 Wanbang Biopharmaceuticals Human Recombinant Insulin SWOT Analysis
11.9.6 Wanbang Biopharmaceuticals Recent Developments
11.10 Dongbao Enterprise Group
11.10.1 Dongbao Enterprise Group Corporation Information
11.10.2 Dongbao Enterprise Group Overview
11.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Dongbao Enterprise Group Human Recombinant Insulin Products and Services
11.10.5 Dongbao Enterprise Group Human Recombinant Insulin SWOT Analysis
11.10.6 Dongbao Enterprise Group Recent Developments
11.11 PeproTech
11.11.1 PeproTech Corporation Information
11.11.2 PeproTech Overview
11.11.3 PeproTech Human Recombinant Insulin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 PeproTech Human Recombinant Insulin Products and Services
11.11.5 PeproTech Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Human Recombinant Insulin Value Chain Analysis
12.2 Human Recombinant Insulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Recombinant Insulin Production Mode & Process
12.4 Human Recombinant Insulin Sales and Marketing
12.4.1 Human Recombinant Insulin Sales Channels
12.4.2 Human Recombinant Insulin Distributors
12.5 Human Recombinant Insulin Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Human Recombinant Insulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Rapid-Acting Human Insulin
Table 3. Major Manufacturers of Regular (Short Acting) Insulin
Table 4. Major Manufacturers of NPH (Intermediate Acting) Insulin
Table 5. Major Manufacturers of Long-Acting Human Insulin
Table 6. Major Manufacturers of Premixed Human Insulins Insulin
Table 7. Global Human Recombinant Insulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Human Recombinant Insulin Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 9. Global Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)
Table 10. Global Human Recombinant Insulin Sales Market Share by Region (2017-2022)
Table 11. Global Human Recombinant Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Human Recombinant Insulin Revenue Market Share by Region (2017-2022)
Table 13. Global Human Recombinant Insulin Sales Forecast by Region (2023-2028) & (K Litre)
Table 14. Global Human Recombinant Insulin Sales Market Share Forecast by Region (2023-2028)
Table 15. Global Human Recombinant Insulin Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 16. Global Human Recombinant Insulin Revenue Market Share Forecast by Region (2023-2028)
Table 17. Top Human Recombinant Insulin Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 18. Human Recombinant Insulin Market Trends
Table 19. Human Recombinant Insulin Market Drivers
Table 20. Human Recombinant Insulin Market Challenges
Table 21. Human Recombinant Insulin Market Restraints
Table 22. Global Human Recombinant Insulin Sales by Manufacturers (2017-2022) & (K Litre)
Table 23. Global Human Recombinant Insulin Sales Share by Manufacturers (2017-2022)
Table 24. Global Human Recombinant Insulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Ranking of Global Top Human Recombinant Insulin Manufacturers by Revenue (US$ Million) in 2021
Table 26. Human Recombinant Insulin Revenue Share by Manufacturers (2017-2022)
Table 27. Global Human Recombinant Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Recombinant Insulin as of 2021)
Table 29. Key Manufacturers Human Recombinant Insulin Average Selling Price (ASP) & (2017-2022) & (USD/Litre)
Table 30. Key Manufacturers Human Recombinant Insulin Plants/Factories Distribution
Table 31. Key Manufacturers Human Recombinant Insulin Area Served
Table 32. Date of Key Manufacturers Enter into Human Recombinant Insulin Market
Table 33. Key Manufacturers Human Recombinant Insulin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Human Recombinant Insulin Sales (K Litre) by Type (2017-2022)
Table 36. Global Human Recombinant Insulin Sales Share by Type (2017-2022)
Table 37. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Type (2017-2022)
Table 38. Global Human Recombinant Insulin Price (K Litre) by Type (2017-2022)
Table 39. Global Human Recombinant Insulin Sales (K Litre) by Type (2023-2028)
Table 40. Global Human Recombinant Insulin Sales Share by Type (2023-2028)
Table 41. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Type (2023-2028)
Table 42. Global Human Recombinant Insulin Revenue Share by Type (2023-2028)
Table 43. Global Human Recombinant Insulin Price (K Litre) by Type (2023-2028)
Table 44. Global Human Recombinant Insulin Sales (K Litre) by Application (2017-2022)
Table 45. Global Human Recombinant Insulin Sales Share by Application (2017-2022)
Table 46. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Application (2017-2022)
Table 47. Global Human Recombinant Insulin Price (K Litre) by Application (2017-2022)
Table 48. Global Human Recombinant Insulin Sales (K Litre) by Application (2023-2028)
Table 49. Global Human Recombinant Insulin Sales Share by Application (2023-2028)
Table 50. Global Human Recombinant Insulin Revenue (US$ Million) Market Share by Application (2023-2028)
Table 51. Global Human Recombinant Insulin Revenue Share by Application (2023-2028)
Table 52. Global Human Recombinant Insulin Price (K Litre) by Application (2023-2028)
Table 53. North America Human Recombinant Insulin Sales by Company (2017-2022) & (K Litre)
Table 54. North America Human Recombinant Insulin Sales Market Share by Company (2017-2022)
Table 55. North America Human Recombinant Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 56. North America Human Recombinant Insulin Revenue Market Share by Company (2017-2022)
Table 57. North America Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 58. North America Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 59. North America Human Recombinant Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 60. North America Human Recombinant Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 61. North America Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 62. North America Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 63. North America Human Recombinant Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 64. North America Human Recombinant Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 65. North America Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 66. North America Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 67. North America Human Recombinant Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 68. North America Human Recombinant Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Europe Human Recombinant Insulin Sales by Company (2017-2022) & (K Litre)
Table 70. Europe Human Recombinant Insulin Sales Market Share by Company (2017-2022)
Table 71. Europe Human Recombinant Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 72. Europe Human Recombinant Insulin Revenue Market Share by Company (2017-2022)
Table 73. Europe Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 74. Europe Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 75. Europe Human Recombinant Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 76. Europe Human Recombinant Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 77. Europe Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 78. Europe Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 79. Europe Human Recombinant Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 80. Europe Human Recombinant Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 81. Europe Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 82. Europe Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 83. Europe Human Recombinant Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 84. Europe Human Recombinant Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 85. Asia Pacific Human Recombinant Insulin Sales by Company (2017-2022) & (K Litre)
Table 86. Asia Pacific Human Recombinant Insulin Sales Market Share by Company (2017-2022)
Table 87. Asia Pacific Human Recombinant Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 88. Asia Pacific Human Recombinant Insulin Revenue Market Share by Company (2017-2022)
Table 89. Asia Pacific Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 90. Asia Pacific Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 91. Asia Pacific Human Recombinant Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 92. Asia Pacific Human Recombinant Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 93. Asia Pacific Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 94. Asia Pacific Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 95. Asia Pacific Human Recombinant Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 96. Asia Pacific Human Recombinant Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 97. Asia Pacific Human Recombinant Insulin Sales by Region (2017-2022) & (K Litre)
Table 98. Asia Pacific Human Recombinant Insulin Sales by Region (2023-2028) & (K Litre)
Table 99. Asia Pacific Human Recombinant Insulin Revenue by Region (2017-2022) & (US$ Million)
Table 100. Asia Pacific Human Recombinant Insulin Revenue by Region (2023-2028) & (US$ Million)
Table 101. Latin America Human Recombinant Insulin Sales by Company (2017-2022) & (K Litre)
Table 102. Latin America Human Recombinant Insulin Sales Market Share by Company (2017-2022)
Table 103. Latin America Human Recombinant Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 104. Latin America Human Recombinant Insulin Revenue Market Share by Company (2017-2022)
Table 105. Latin America Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 106. Latin America Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 107. Latin America Human Recombinant Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 108. Latin America Human Recombinant Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 109. Latin America Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 110. Latin America Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 111. Latin America Human Recombinant Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 112. Latin America Human Recombinant Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 113. Latin America Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 114. Latin America Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 115. Latin America Human Recombinant Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 116. Latin America Human Recombinant Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 117. Middle East and Africa Human Recombinant Insulin Sales by Company (2017-2022) & (K Litre)
Table 118. Middle East and Africa Human Recombinant Insulin Sales Market Share by Company (2017-2022)
Table 119. Middle East and Africa Human Recombinant Insulin Revenue by Company (2017-2022) & (US$ Million)
Table 120. Middle East and Africa Human Recombinant Insulin Revenue Market Share by Company (2017-2022)
Table 121. Middle East and Africa Human Recombinant Insulin Sales by Type (2017-2022) & (K Litre)
Table 122. Middle East and Africa Human Recombinant Insulin Sales by Type (2023-2028) & (K Litre)
Table 123. Middle East and Africa Human Recombinant Insulin Revenue by Type (2017-2022) & (US$ Million)
Table 124. Middle East and Africa Human Recombinant Insulin Revenue by Type (2023-2028) & (US$ Million)
Table 125. Middle East and Africa Human Recombinant Insulin Sales by Application (2017-2022) & (K Litre)
Table 126. Middle East and Africa Human Recombinant Insulin Sales by Application (2023-2028) & (K Litre)
Table 127. Middle East and Africa Human Recombinant Insulin Revenue by Application (2017-2022) & (US$ Million)
Table 128. Middle East and Africa Human Recombinant Insulin Revenue by Application (2023-2028) & (US$ Million)
Table 129. Middle East and Africa Human Recombinant Insulin Sales by Country (2017-2022) & (K Litre)
Table 130. Middle East and Africa Human Recombinant Insulin Sales by Country (2023-2028) & (K Litre)
Table 131. Middle East and Africa Human Recombinant Insulin Revenue by Country (2017-2022) & (US$ Million)
Table 132. Middle East and Africa Human Recombinant Insulin Revenue by Country (2023-2028) & (US$ Million)
Table 133. Novo Nordisk Corporation Information
Table 134. Novo Nordisk Description and Overview
Table 135. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 136. Novo Nordisk Human Recombinant Insulin Product and Services
Table 137. Novo Nordisk Human Recombinant Insulin SWOT Analysis
Table 138. Novo Nordisk Recent Developments
Table 139. Eli Lilly and Company Corporation Information
Table 140. Eli Lilly and Company Description and Overview
Table 141. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 142. Eli Lilly and Company Human Recombinant Insulin Product and Services
Table 143. Eli Lilly and Company Human Recombinant Insulin SWOT Analysis
Table 144. Eli Lilly and Company Recent Developments
Table 145. Sanofi Corporation Information
Table 146. Sanofi Description and Overview
Table 147. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 148. Sanofi Human Recombinant Insulin Product and Services
Table 149. Sanofi Human Recombinant Insulin SWOT Analysis
Table 150. Sanofi Recent Developments
Table 151. Julphar Gulf Pharmaceutical Industries Corporation Information
Table 152. Julphar Gulf Pharmaceutical Industries Description and Overview
Table 153. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 154. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product and Services
Table 155. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin SWOT Analysis
Table 156. Julphar Gulf Pharmaceutical Industries Recent Developments
Table 157. Bioton Corporation Information
Table 158. Bioton Description and Overview
Table 159. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 160. Bioton Human Recombinant Insulin Product and Services
Table 161. Bioton Human Recombinant Insulin SWOT Analysis
Table 162. Bioton Recent Developments
Table 163. Gan & Lee Pharmaceuticals Corporation Information
Table 164. Gan & Lee Pharmaceuticals Description and Overview
Table 165. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 166. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product and Services
Table 167. Gan & Lee Pharmaceuticals Human Recombinant Insulin SWOT Analysis
Table 168. Gan & Lee Pharmaceuticals Recent Developments
Table 169. Zhuhai United Laboratories Corporation Information
Table 170. Zhuhai United Laboratories Description and Overview
Table 171. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 172. Zhuhai United Laboratories Human Recombinant Insulin Product and Services
Table 173. Zhuhai United Laboratories Human Recombinant Insulin SWOT Analysis
Table 174. Zhuhai United Laboratories Recent Developments
Table 175. Biocon Corporation Information
Table 176. Biocon Description and Overview
Table 177. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (US$ Million), Average Selling Price (ASP) (USD/Litre) and Gross Margin (2017-2022)
Table 178. Biocon Human Recombinant Insulin Product and Services
Table 179. Biocon Human Recombinant Insulin SWOT Analysis
Table 180. Biocon Recent Developments
Table

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs